SCHEMBL22525838

SCHEMBL22525838

CC(=O)CCCCCc1ccc(Cl)c(OCC(C)C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ LMNA P02545 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ PTGER1 P34995 1/20 0.37
▸ PPARG P37231 1/20 0.37
▸ PPARA Q07869 1/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ ACACB O00763 1/20 0.36
▸ ALOX5 P09917 1/20 0.36
▸ TRPV1 Q8NER1 1/20 0.36
▸ PYGL P06737 1/20 0.36
▸ S1PR1 P21453 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26203896 0.89 PTGER1 (0.39) TSHRTDP1L3MBTL1LMNATP53
SCHEMBL29307148 0.88 TSHR (0.37) TSHRTDP1L3MBTL1LMNATP53
SCHEMBL22526055 0.85 CYP4F2 (0.41) NPC1RAB9APPARGPPARA
SCHEMBL11640050 0.78 IGF1R (0.56) TSHRTP53MEN1KMT2ATRPV1
SCHEMBL23842320 0.78 PPARG (0.40) LMNAPPARGPPARAMEN1KMT2A
SCHEMBL25123141 0.77 PPARG (0.38) PPARGPPARAMEN1KMT2AACACB
SCHEMBL26229267 0.77 MEN1 (0.38) PPARGPPARAMEN1KMT2AALOX5
SCHEMBL26206371 0.76 S1PR1 (0.39) PPARGACACBALOX5S1PR1
SCHEMBL23845448 0.75 PPARA (0.50) PPARGPPARA
SCHEMBL23842319 0.75 KEAP1 (0.42) TSHRPPARGPPARAALOX5S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020206424-A1 STAT DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2020-10-08 — — WO disclosed
Send feedback